Results 71 to 80 of about 1,776 (189)
Cancer Medicine, Volume 15, Issue 1, January 2026.The debate in the field of cancer immunotherapy is being changed as nanotechnology breaks the obstacle of cancer immune evasion, target delivery, and systemic toxicity. Esthetically advanced methods that are discussed in this review are nanovaccine, nanoparticle‐enabled checkpoint barrier, cytokine delivery, and T‐cell modulation techniques that ...
Daniel Ejim Uti +7 more
wiley +1 more source
Targeted therapy in nuclear medicine—current status and future prospects [PDF]
, 2017 In recent years, a number of new developments in targeted therapies using radiolabeled compounds have emerged. New developments and insights in radioiodine treatment of thyroid cancer, treatment of lymphoma and solid tumors with radiolabeled monoclonal ...
Bodei, L. +6 more
core
ChemBioChem, Volume 27, Issue 1, January 2026.Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh +7 more
wiley +1 more source
Medicinal Research Reviews, Volume 46, Issue 1, Page 203-237, January 2026.ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller +5 more
wiley +1 more source
Biocompatible Chemistry: A Plug‐and‐Play Toolbox for Chemical Biology Research
ChemBioChem, Volume 26, Issue 23, November 27, 2025.The “plug‐and‐play” nature of biocompatible chemistry makes it a powerful toolbox for investigating complicated biological systems and producing drug leads for clinical usages. This review summarizes the commonly used biocompatible reactions and the recent advances of their representative applications in chemical biology research, thus highlighting the
Adam R. Lovato, Zeng Lin, Qingfei Zheng
wiley +1 more source
Comparative efficacy of 177Lu and 90Y for anti-CD20 pretargeted radioimmunotherapy in murine lymphoma xenograft models. [PDF]
PLoS ONE, 2015 Pretargeted radioimmunotherapy (PRIT) is a multi-step method of selectively delivering high doses of radiotherapy to tumor cells while minimizing exposure to surrounding tissues.
Sofia H L Frost +12 more
doaj +1 more source
Bevacizumab radioimmunotherapy (RIT) with accelerated blood clearance using the avidin chase [PDF]
, 2018 学位記番号 ...
RYAN, YUDISTIRO +1 more
core
New insights into the pretargeting approach to image and treat tumours
Chemical Society Reviews, 2016 This tutorial review describes the fundamental concept of tumour pretargeting, highlights the historical as well as recent advances of this strategy and discusses the advantages and disadvantages of different available variations.
Malay Patra +4 more
openaire +3 more sources
Circulating Tumor Cell‐Derived Organoids: Current Progress, Applications, and Future
MedComm – Future Medicine, Volume 4, Issue 3, September 2025.CTC‐derived organoids, which combine the characteristics of patient‐derived organoids and circulating tumor cells (CTCs), represent a novel tool in cancer research. This article reviews the progress, applications, and future prospects of CTC‐derived organoids.
Tiantian Li +5 more
wiley +1 more source
Biomedicines, 2020 (1) Background: Stereotactic body radiotherapy (SBRT) for vertebral metastases (VM) allows the delivery of high radiation doses to tumors while sparing the spinal cord.
Baptiste Pichon +11 more
doaj +1 more source